Jfs Wealth Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History
Jfs Wealth Advisors, LLC
- $1.46 Billion
- Q4 2024
A detailed history of Jfs Wealth Advisors, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 15 shares of AGIO stock, worth $479. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$479
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$182 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$180 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$155 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$112 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$77.5 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.75B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...